NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia

IntroductionAcute myeloid leukemia (AML) is an aggressive blood cancer with high heterogeneity and poor prognosis. Although the metabolic reprogramming of nicotinamide adenine dinucleotide (NAD) has been reported to play a pivotal role in the pathogenesis of acute myeloid leukemia (AML), the prognos...

Повний опис

Бібліографічні деталі

Автори:	Yuncan Cao, Wenjing Shu, Peng Jin, Jianfeng Li, Hongming Zhu, Xinjie Chen, Yongmei Zhu, Xi Huang, Wenyan Cheng, Yang Shen
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-06-01
Серія:	Frontiers in Immunology
Предмети:	acute myeloid leukemia NAD metabolism prognostic signature immune microenvironment targeted therapy
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1417398/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!